Total Funding
1
Total FundingSeed raised
Growth Score
pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
4357130
CymoGen Dx is a genomic diagnostic company engaged in the development and application of fluorescence-based DNA detection technologies.
Thomas J. Moss: Chief Medical Officer
About the Company
CymoGen Dx, LLC, a genomic diagnostic technology company, provides genomic-based reagents and fluorescent in-situ hybridization probes research products and solutions for the diagnosis and monitoring of cancers and human genetic disorders for clinical, biopharmaceutical, and research customers. It engages in the development, manufacture, and
application of fluorescence-based DNA detection technology. The company provides tools for identifying genomic aberrations in cancer cells found in tissue and bone marrow specimens. CymoGen Dx, LLC was formerly known as CymoGen, LLC. The company was incorporated in 2010 and is based in New Windsor, New York.
